HELP
HELP
NASDAQ · Pharmaceuticals

Cybin Inc

$8.96
+0.57 (+6.79%)
As of Nov 7, 2:59 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +8.5% upside
Low Target $6.32
Average Target $9.72
High Target $10.76
Current Price $8.96
Current
$8.96
Target
$9.72
$6.32 $9.72 avg $10.76
Scenario Analysis
Bear Case
$6.32
-29.5%
Low target
Base Case
$9.72
+8.5%
Avg target
Bull Case
$10.76
+20.1%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$20.88
-57.1% from high
52-Week Low
$5.30
+69.1% from low
Target vs 52W High
$9.72
-53.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%